First Trust Nasdaq Pharmaceuticals ETF (FTXH) Short Interest Ratio & Short Volume $26.55 +0.13 (+0.49%) Closing price 08/5/2025 03:19 PM EasternExtended Trading$25.82 -0.73 (-2.75%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Short Interest DataFirst Trust Nasdaq Pharmaceuticals ETF (FTXH) has a short interest of 2,000 shares. This marks a -67.74% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 7,938 shares to cover all short positions.Current Short Interest2,000 sharesPrevious Short Interest6,200 sharesChange Vs. Previous Month-67.74%Dollar Volume Sold Short$51.97 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares550,000 sharesPercentage of Shares Shorted0.36%Today's Trading Volume1,855 sharesAverage Trading Volume7,938 sharesToday's Volume Vs. Average23% Short Selling First Trust Nasdaq Pharmaceuticals ETF? Sign up to receive the latest short interest report for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFTXH Short Interest Over TimeFTXH Days to Cover Over TimeFTXH Percentage of Float Shorted Over Time First Trust Nasdaq Pharmaceuticals ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20252,000 shares $51.97 thousand -67.7%N/A0.1 $25.99 6/30/20256,200 shares $158.91 thousand -47.0%1.1%0.4 $25.63 6/15/202511,700 shares $305.37 thousand +8.3%2.1%0.8 $26.10 5/31/202510,800 shares $276.36 thousand -10.0%1.3%1 $25.59 5/15/202512,000 shares $298.08 thousand +166.7%2.2%1.1 $24.84 4/30/20254,500 shares $116.08 thousand +1,400.0%N/A0.4 $25.80 4/15/2025300 shares $7.32 thousand -57.1%0.1%0.1 $24.39 3/31/2025700 shares $19.27 thousand +40.0%0.1%0.2 $27.53 3/15/2025500 shares $13.99 thousand -37.5%0.1%0.2 $27.97 2/28/2025800 shares $22.49 thousand +14.3%0.2%0.3 $28.11 Get the Latest News and Ratings for FTXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025700 shares $19.08 thousand -41.7%0.1%0.3 $27.25 1/31/20251,200 shares $33.29 thousand +33.3%N/A0.4 $27.74 1/15/2025900 shares $24.29 thousand -40.0%N/A0.4 $26.99 12/31/20241,500 shares $40.46 thousand +275.0%N/A0.6 $26.97 12/15/2024400 shares $10.92 thousand +100.0%N/A0.1 $27.29 11/30/2024200 shares $5.67 thousand -81.8%N/A0.1 $28.36 11/15/20241,100 shares $29.81 thousand -62.1%N/A0.3 $27.10 10/31/20242,900 shares $81.98 thousand +93.3%N/A0.8 $28.27 10/15/20241,500 shares $43.35 thousand +200.0%N/A0.4 $28.90 9/30/2024500 shares $14.42 thousand +66.7%N/A0.1 $28.84 9/15/2024300 shares $8.76 thousand -66.7%N/A0.1 $29.19 8/31/2024900 shares $26.69 thousand +200.0%N/A0.2 $29.66 8/15/2024300 shares $8.58 thousand -85.0%N/A0.1 $28.59 7/31/20242,000 shares $57.10 thousand +25.0%N/A0.4 $28.55 7/15/20241,600 shares $44.83 thousand No ChangeN/A0.3 $28.02 2/15/20241,000 shares $27.80 thousand -66.7%N/A0.1 $27.80 1/31/20243,000 shares $80.91 thousand -44.4%N/A0.4 $26.97 1/15/20245,400 shares $147.37 thousand +500.0%N/A0.7 $27.29 12/31/2023900 shares $23.95 thousand -35.7%N/A0.1 $26.62 12/15/20231,400 shares $36.65 thousand +1,300.0%N/A0.2 $26.18 11/30/2023100 shares $2.50 thousand -66.7%N/A0 $24.98 11/15/2023300 shares $7.37 thousand +200.0%N/A0 $24.56 10/31/2023100 shares $2.40 thousand -66.7%N/A0 $24.04 10/15/2023300 shares $7.68 thousand +50.0%N/A0 $25.61 9/30/2023200 shares $5.11 thousand -89.5%N/A0 $25.57 9/15/20231,900 shares $50.16 thousand -77.1%N/A0.2 $26.40 8/31/20238,300 shares $223.02 thousand +8,200.0%N/A0.6 $26.87 8/15/2023100 shares $2.71 thousand -66.7%N/A0 $27.05 7/31/2023300 shares $7.96 thousand -66.7%N/A0 $26.54 7/15/2023900 shares $23.42 thousand -76.3%N/A0.1 $26.02If you saw this, you'd be scared too (Ad)Markets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ years of navigating crashes and crises, he says traditional strategies could soon become wealth destroyers. A time-sensitive briefing reveals what to do now.Watch his urgent warning before this “dark day” hits 6/30/20233,800 shares $99.52 thousand -28.3%N/A0.3 $26.19 6/15/20235,300 shares $140.82 thousand -15.9%N/A0.6 $26.57 5/31/20236,300 shares $161.03 thousand +6,200.0%N/A0.5 $25.56 5/15/2023100 shares $2.66 thousand -66.7%N/A0 $26.62 4/30/2023300 shares $7.98 thousand -25.0%N/A0 $26.60 4/15/2023400 shares $10.76 thousand -20.0%N/A0 $26.90 3/31/2023500 shares $13.05 thousand +400.0%N/A0 $26.10 3/15/2023100 shares $2.55 thousand -99.0%N/A0 $25.53 2/28/20239,500 shares $249.85 thousand -65.5%N/A0.7 $26.30 2/15/202327,500 shares $749.29 thousand +19.6%N/A2.4 $27.25 1/31/202323,000 shares $633.19 thousand -9.1%N/A2.1 $27.53 1/15/202325,300 shares $707.66 thousand +94.6%N/A2.1 $27.97 12/30/202213,000 shares $356.59 thousand -41.2%N/A0.9 $27.43 12/15/202222,100 shares $612.61 thousand -29.2%N/A1.7 $27.72 11/30/202231,200 shares $874.54 thousand +339.4%N/A2.4 $28.03 11/15/20227,100 shares $190.99 thousand +153.6%N/A0.6 $26.90 10/31/20222,800 shares $74.03 thousand +64.7%N/A0.2 $26.44 10/15/20221,700 shares $41.75 thousand No ChangeN/A0.1 $24.56 9/30/20223,700 shares $88.95 thousand -28.9%N/A0.2 $24.04 9/15/20225,200 shares $130.05 thousand -27.8%N/A0.1 $25.01 8/31/20227,200 shares $179.14 thousand -56.9%N/A0.1 $24.88 8/15/202216,700 shares $445.22 thousand +18.4%N/A0.3 $26.66 7/31/202214,100 shares $373.51 thousand +93.2%N/A0.3 $26.49 7/15/20227,300 shares $194.76 thousand No ChangeN/A0.2 $26.68 2/15/20226,100 shares $156.83 thousand -10.3%N/A2 $25.71 1/31/20226,800 shares $175.30 thousand -13.9%N/A2.2 $25.78 1/15/20227,900 shares $203.43 thousand -16.8%N/A2.5 $25.75 12/31/20219,500 shares $257.07 thousand +4.4%N/A3.4 $27.06 12/15/20219,100 shares $240.06 thousand +810.0%N/A3.5 $26.38 11/30/20211,000 shares $25.47 thousand -23.1%N/A0.4 $25.47 11/15/20211,300 shares $35.10 thousand +44.4%N/A0.3 $27.00 10/29/2021900 shares $23.61 thousand -18.2%N/A0.2 $26.23 10/15/20211,100 shares $28.46 thousand -15.4%N/A0.2 $25.87 9/30/20211,300 shares $33.53 thousand -51.9%N/A0.3 $25.79 9/15/20212,700 shares $69.74 thousand -30.8%N/A0.6 $25.83 8/31/20213,900 shares $104.05 thousand +11.4%N/A0.8 $26.68 8/13/20213,500 shares $93.35 thousand +9.4%N/A1.6 $26.67 7/30/20213,200 shares $84.45 thousand +18.5%N/A1.5 $26.39 7/15/20212,700 shares $69.39 thousand -20.6%N/A1 $25.70 6/30/20213,400 shares $87.99 thousand -71.2%N/A0.9 $25.88 6/15/202111,800 shares $307.63 thousand +35.6%N/A1.8 $26.07 5/28/20218,700 shares $224.44 thousand -3.3%N/A1.1 $25.80 5/14/20219,000 shares $231.32 thousand +20.0%N/A0.8 $25.70 4/30/20217,500 shares $195.21 thousand -40.5%N/A0.6 $26.03 4/15/202112,600 shares $324.39 thousand -44.0%N/A1 $25.75 3/31/202122,500 shares $566.78 thousand -12.5%N/A1.7 $25.19 3/15/202125,700 shares $675.65 thousand +30.5%N/A2.1 $26.29 2/26/202119,700 shares $516.14 thousand -21.2%N/A1.9 $26.20 2/12/202125,000 shares $668.63 thousand -3.9%N/A3.2 $26.75 1/29/202126,000 shares $690.30 thousand +10.2%N/A2.9 $26.55[Shocking New Report] U.S. Dollar To Crash? (Ad)The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Click Here to Keep Reading...National Debt & Your Retirement 1/15/202123,600 shares $634.60 thousand No ChangeN/A2.7 $26.89 FTXH Short Interest - Frequently Asked Questions What is First Trust Nasdaq Pharmaceuticals ETF's current short interest? Short interest is the volume of First Trust Nasdaq Pharmaceuticals ETF shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 2,000 shares of FTXH short. Learn More on First Trust Nasdaq Pharmaceuticals ETF's current short interest. Is First Trust Nasdaq Pharmaceuticals ETF's short interest increasing or decreasing? First Trust Nasdaq Pharmaceuticals ETF saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 2,000 shares, a decline of 67.7% from the previous total of 6,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does First Trust Nasdaq Pharmaceuticals ETF's short interest compare to its competitors? Here is how the short interest of companies compare to First Trust Nasdaq Pharmaceuticals ETF: JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (5.41%), Invesco Nasdaq Biotechnology ETF (0.41%), ProShares Ultra Nasdaq Biotechnology (1.16%), Invesco Dorsey Wright Healthcare Momentum ETF (0.26%), VanEck Biotech ETF (0.27%), VanEck Pharmaceutical ETF (41.19%), and iShares Biotechnology ETF (29.39%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short First Trust Nasdaq Pharmaceuticals ETF stock? Short selling FTXH is an investing strategy that aims to generate trading profit from First Trust Nasdaq Pharmaceuticals ETF as its price is falling. FTXH shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against First Trust Nasdaq Pharmaceuticals ETF? A short squeeze for First Trust Nasdaq Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FTXH, which in turn drives the price of the stock up even further. How often is First Trust Nasdaq Pharmaceuticals ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FTXH, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies JDOC Short Squeeze BIS Short Squeeze IBBQ Short Squeeze BIB Short Squeeze PTH Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FTXH) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts